Neurodegenerative Treatments
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT04008355
A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 22, 2020
Completion: Sep 30, 2024
Loading map...